StraDiVarious is a European doctoral network studying strain variants of ESKAPE pathogens to develop rapid diagnostics and identify therapeutic targets.
EU-funded doctoral network training 15 researchers across 10 institutions
Four integrated work packages spanning genomics, cell biology, structural analysis, and device development
Targeting ESKAPE pathogens through bacterial adhesin analysis
Academic-industry collaboration including pharmaceutical partners
Developing rapid point-of-care diagnostics to distinguish virulent from colonising strains
36-month fully-funded positions with cross-sector secondments
Our hypothesis centres on how small structural variations in bacterial adhesins modulate virulence between strains, enabling us to distinguish "killer" from "coloniser" variants through integrated multiscale analysis.
Fifteen internationally renowned experts from world-class institutions provide supervision, with collective experience supervising over 300 PhD students and publishing more than 2,000 papers in top-tier journals.
For questions about the StraDiVarious network, collaboration opportunities, or general project information, please get in touch with our team.